300149 睿智医药
2026/06 - 中期
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资170,033-3.12%175,513214,463197,494197,018
投资性房地产72,625-1.03%73,38476,01679,21214,185
固定资产306,563-1.67%311,782333,800373,936318,817
在建工程9,973144.98%4,07112,9957,96364,384
无形资产32,350-1.06%32,69530,66130,04853,534
商誉34--00139,260955,991
其他非流动资产639,967-4.55%670,484683,804879,231923,649
1,231,544-2.87%1,267,9281,351,7391,707,1442,527,578

流动资产
货币资金395,221-4.03%411,827368,329347,260761,664
应收账款251,5509.72%229,257176,719263,853341,495
存货17,79587.91%9,47011,44127,88242,817
其他流动资产91,750-19.84%114,46287,58088,185134,384
756,316-1.14%765,017644,069727,1791,280,359

流动负债
短期借款60,100-10.72%67,31658,46960,003115,023
应付票据0--0000
应付帐款58,95817.19%50,30964,02453,79280,698
其他流动负债227,260-4.44%237,820224,205312,980536,310
346,318-2.57%355,445346,698426,775732,031
流动资产净值409,9980.10%409,572297,371300,404548,328
资产总额减流动负债1,641,542-2.14%1,677,5001,649,1102,007,5483,075,906

非流动负债
长期借款23,962-17.14%28,91937,20543,675177,210
应付债券0--0000
其他非流动负债311,901-10.43%348,221373,842502,988528,695
335,862-10.95%377,140411,047546,663705,905

总权益
    实收股本497,9640.00%497,964497,964499,777499,777
    储备项目777,730-0.04%778,053715,897936,8701,845,799
股东权益1,275,694-0.03%1,276,0171,213,8611,436,6472,345,576
非控股权益29,98523.18%24,34224,20224,23924,425